Application Note

In-Process Control Of pDNA Production On CIMac™ pDNA Analytical Column

Source: Sartorius
Sartorius CIM HIP Plasmid Process PackTM, CIMac pDNA

As the demand for plasmid DNA (pDNA) based gene therapy and vaccines increases, large-scale, cost-effective, and reproducible pDNA production is required. The key to success is a real-time in-process control method that ensures a high percentage of supercoiled pDNA in the final product. CIMac™ pDNA Analytical Column allows the monitoring of degradation products (open circular and linear pDNA), the removal of impurities (RNA), and ensures that each production step yields the amount of supercoiled pDNA anticipated.

This application note is an example of a pDNA purification process based on our CIM® HIP² Plasmid Process Pack™ with in-process control steps. The final product composition is confirmed by Agarose Gel Electrophoresis. The complete separation of all three pDNA conformations from a test solution within 10 minutes on the CIMac™ pDNA Analytical Column shows the versatility of the column.

VIEW THE APPLICATION NOTE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Drug Discovery Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: